AFP and hepatocellular carcinoma: Another study demonstrated that the diagnostic accuracy for HBV-HCC is significantly improved when AFP, PIVKA-II, and golgi glycoprotein 73 (GP73) are used together, particularly in the chronic hepatitis B patient population [453].